National – US Strategies
- Healthy People 2030
- National Drug Control Strategy (ONDCP) (2024)
- Overdose Detection Mapping Application Program (ODMAP) – Statewide Implementation Strategies (2024)
- Prevention with Purpose: A Strategic Planning Guide for Preventing Drug Misuse Among College Students (DEA 2024)
- Implementing Best Practices Across the Continuum of Care to Prevent Overdose – A Roadmap for Governor’s (2023)
- Federal Register: Continuation of the National Emergency With Respect to the Global Illicit Drug Trade (Dec 2023)
- 2023 State of the States: Legislative Roadmap for Reducing Overdose Deaths and Increasing Access to Treatment (LAPPA – Nov 2023)
- AMA – State Toolkit to End the Nation’s Drug Overdose Epidemic (2022)
- CBP Strategy to Combat Fentanyl and Other Synthetic Drugs (Oct 2023)
- CBP Strategy to Combat Fentanyl and Other Synthetic Drugs – Fact Sheet (Oct 2023)
- CMS Strategic Framework (2023)
- National Drug Threat Assessment (NDTA) (DEA 2024)
- FDA – Overdose Prevention Framework (2023)
- FDA – Overdose Prevention Framework – Fact Sheet (2022)
- FDA – Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention
- Fentanyl Adulterated or Associated with Xylazine Response Plan (ONDCP – July 2023)
- HHS – Overdose Prevention Strategy
- National Drug Control Strategy (ONDCP) (2022)
- ORS – Overdose Response Strategy
- Substance Abuse and Mental Health Services Administration (SAMHSA) – Interim Strategic Plan (Nov 2022)
- Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One (2021)
- CMS – Behavioral Health Strategy
- CMS Action Plan to Enhance Prevention and Treatment for Opioid Use Disorder (2021)
- National Association of Counties (NACo) – Approved Strategies
- National Drug Control Strategy (ONDCP) (2020)
- Tribal Opioid Response – National Strategic Agenda (2019)
- National Drug Control Strategy (ONDCP) (2019)
- National Institute on Drug Abuse – 2022-2026 NIDA Strategic Plan
- National Opioids Settlement Webpage
- National Opioid Settlement – Distributor Settlement Agreement (Final 3/25/22)
- Primer on Spending Funds from the Opioid Litigation – A guide for State and Local Decision Makers
- The President’s Commission on Combating Drug Addiction and the Opioid Crisis – 11/15/2017
- SAMHSA – Strategic Plan 2023-2026 (Released Aug 2023)
- Determination that a Public Health Emergency Exists – HHS 10/26/2017
Menu
National – General Programs
- AACAP – American Academy of Child & Adolescent Psychiatry
- All Rise – (Formerly National Association of Drug Court Professionals NADCP)
- AAP – American Academy of Pediatrics
- AATOD – American Association for the Treatment of Opioid Dependence, Inc.
- ACMT – American College of Medical Toxicology
- AfBPM – Alliance for Balance Pain Management
- AFSA – Americans For Safe Access – Advancing Legal Medical Marijuana Therapeutics and Research
- AHA – American Hospital Association
- Altarum
- AMA – American Medical Association
- America’s Poison Centers
- APF – Addiction Policy Forum
- APHA – American Public Health Association
- ARS – Association of Recovery Schools
- ASAM – American Society of Addiction Medicine
- ASOP Global – Alliance for Safe Online Pharmacies
- ASOP Global Foundation
- ASTHO – Association of State and Territorial Health Officials
- ATSDR – Agency for Toxic Substances and Disease Registry
- ATTC – Addiction Technology Transfer Center Network
- BJA – Bureau of Justice Assistance
- CADCA – Community Anti-Drug Coalitions of America
- Campaign for Tobacco Free Kids
- Campus Drug Prevention
- CBHSQ – SAMHSA Center for Behavioral Health Statistics and Quality
- CDC – US Center for Disease Control and Prevention
- CDC Foundation
- CEPOP – Collaborative for Effective Prescription Opioid Policies
- cfsre – Center for Forensic Science Research & Education
- CMS – Centers for Medicare & Medicaid Services
- COSSUP – Comprehensive Opioid, Stimulant, and Substance Use Program (BJA)
- CSAP – SAMHSA Center for Substance Abuse Prevention
- CSAT – SAMHSA Center for Substance Abuse Treatment
- CSG – The Council of State Governments
- CYFAR – Children, Youth, and Families at Risk Program (University of Minnesota)
- DARE – Drug Abuse Resistance Education
- DEA – Drug Enforcement Administration
- DEA – Drug Enforcement Administration – Diversion Control Division
- DFAF – Drug Free America Foundation
- DODIG – Department of Defense – Office of Inspector General
- FAVOR – Faces and Voices of Recovery
- FBI – Federal Bureau of Investigations
- FDA – Food & Drug Administration
- FSMB – Federation of State Medical Boards
- FORE – Foundation for Opioid Response
- GAO – U.S. Government Accountability Office
- GHSA – Governors Highway Safety Association
- GLEPHA – Global Law Enforcement & Public Health Association
- Healthcare Ready
- HHS – US Department of Health and Human Services
- HRSA – Health Resources & Services Administration
- IHS – Indian Health Service
- IIR – Institute for Intergovernmental Research
- IACLEA – International Association of Campus Law Enforcement Administrators
- IAHSS – International Association for Healthcare Security & Safety
- JCOIN – Justice Community Opioid Innovation Network – Coordination and Translation Center (CTC)
- LAPPA – Legislative Analysis And Public Policy Association
- MHS – Military Health System
- NABP – National Association of Boards of Pharmacy
- NACo – National Association of Counties
- NACoA – National Association for Children of Addiction
- NACCHO – National Association of County and City Health Officials
- NADDI – National Association of Drug Diversion Investigators, Inc.
- NAIHC – National American Indian Housing Council
- NAMI – National Alliance on Mental Illness
- NAMSDL – The National Alliance for Model State Drug Laws
- NASADAD – National Association of State Alcohol and Drug Abuse Directors
- NASCSA – National Association of State Controlled Substances Authorities
- NASID – National Alliance to Stop Impaired Driving
- NASTAD – National Alliance of State and Territorial AIDS Directors
- National DEC – National Alliance for Drug Endangered Children
- NCAI – National Congress of American Indians
- NCCIH – National Center for Complementary and Integrative Health
- NCDAS – National Center for Drug Abuse Statistics
- NCJA – National Criminal Justice Association
- NCMW – National Council for Mental Wellbeing
- NCSACW – National Center on Substance Abuse and Child Welfare
- NCYI – National Center for Youth Issues
- NCPC – National Crime Prevention Council
- NCPDP – National Council for Prescription Drug Programs
- NCSL – National Conference of State Legislatures (NCSL)
- NCOA – National Council on Aging
- NDASA – National Drug & Alcohol Screening Association
- NDSN – National Drug Strategy Network
- NDWA – National Drug-Free Workplace Alliance
- NFP – National Family Partnership
- NHCHC – National Health Care for the Homeless Council
- NIAAA – National Institute on Alcohol Abuse and Alcoholism
- NIC – National Institute of Corrections
- NIDA – National Institute on Drug Abuse
- NIH – National Institutes of Health
- NIOSH – National Institute for Occupational Safety and Health
- NMI – National Marijuana Initiative (HIDTA)
- NSA – National Sheriff’s Association – Opioid Resource Library
- NSC – National Safety Council
- NTCRC – National Treatment Court Resource Center
- OASH – Office of Population Affairs – US Department of Health & Human Services
- OAYI – Opioid Affected Youth Initiative
- ODPHP – Office of Disease Prevention and Health Promotions
- OJJDP – Office of Juvenile Justice and Delinquency Prevention
- ONDCP – Office of National Drug Control Policy
- ORRP – Opioid Rapid Response Program
- ORS – Overdose Response Strategy
- Partnership to End Addiction
- PAARI – Police Assisted Addiction & Recovery Initiative
- PDAPS – Prescription Drug Abuse Policy System
- PDMP-TTAC – Prescription Drug Monitoring Program Training and Technical Assistance Center
- The PEW Charitable Trusts
- Poe Center
- PSM – The Partnership for Safe Medicines
- RADARS System – Surveillance of Prescription Drug Abuse, Misuse and Diversion
- R Street Institute
- RTI International
- SADD – Students Against Destructive Decisions
- SAM – Smart Approaches to Marijuana
- SAMHSA – Substance Abuse and Mental Health Services Administration
- SNOW – State and National Overdose Web
- SOS – Save Our Society From Drugs
- TASC – Treatment Alternatives for Safer Communities
- ToxIC – Toxicology Investigators Consortium
- Trust for America’s Health
- UNODC – United Nations Office on Drugs and Crime
- US Department of Health & Human Services (HHS) – National Opioids Crisis: Help and Resources
- USSC – US Sentencing Commission
- VA – Veterans Affairs – Office of Inspector General
- Victoria’s Voice Foundation
- We Believe
- White House Challenge – Saving Lives From Overdose
- WFAD – World Federation Against Drugs
- WHO – World Health Organization
- YPR – Young People in Recovery
National – Data Resource Systems
- American’s Poison Centers – National Poison Data System
- AHRQ – Agency for Healthcare Research and Quality
- CDC – National Vital Statistics System (NVSS) – Drug Overdose Deaths
- CDC – Center for Disease Control and Prevention – NCHS
- CDC – Drug Overdose Surveillance and Epidemiology (DOSE) System
- FBI – Federal Crime Data Explorer – National Data
- FRED – Simulator for Opioid Use Disorder and Overdose
- Healthcare Cost and Utilization Project (H-CUP)
- NCDAS – National Center for Drug Abuse Statistics
- NEMSIS – National Emergency Medical Services Information System
- NORC – Drug Overdose Deaths in the United States
- NPDS – National Poison Data System
- NPLEx – National Precursor Log Exchange
- NSDUH – National Survey on Drug Use and Health
- ODMAP – Overdose Detection Mapping Application Program
- PDAPS – Prescription Drug Abuse Policy System
- RADARS – StreetRx
- SAMHSA – Data and Dissemination
- SAMHSA – Data Analysis System Website (DataTools)
- SNOW – State and National Overdose Web
- ToxIC – Toxicology Investigators Consortium
- UNDOC – Early Warning Advisory on New Psychoactive Substances
- VERA – Overdose Deaths and Jail Incarceration
National – Drug Advertising
- Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format Final Rule Questions and Answers Guidance for Industry (Small Entity Compliance Guide) (December 2023)
- Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in a Clear, Conspicuous, and Neutral Manner in Advertisements in Television and Radio Format (Fed Reg 11/21/2023)
- FDA – Prescription Drug Advertising
National – Drug Alerts & Warnings
- CDC – Health Alert Network (HAN)
- cfsre – Center for Forensic Science Research & Education – Public Alerts
- Drugs.com – FDA Medwatch Alerts
- FDA – Alerts, Advisories & Safety Information
- FDA – Drug Alerts and Statements
- NCCIH – Alerts and Advisories
- NDEWS – National Drug Early Warning System
- DEA Issues Warning About Illegal Online Pharmacies (10/4/2024)
- Drugs.com – FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products (7/16/2024)
- Drug.com – Supercore Issues Voluntary Worldwide Recall of Hard Steel Capsules & Gold Hard Steel Plus Liquid Due to the Presence of Sildenafil and Acetaminophen (7/12/2024)
- CDC HAN – Disrupted Access to Prescription Stimulant Medications Could Increase Risk of Injury and Overdose (6/13/2024)
- CDC HAN – Severe Illness Potentially Associated with Consuming Diamond ShruumzTM Brand Chocolate Bars, Cones, and Gummies (6/12/2024)
- FDA warns consumers not to purchase or use Neptune’s Fix or any tianeptine product due to serious risks (2/15/2024)
- DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine (3/20/2023)
- FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs (11/8/2022)
- DEA Warns of Brightly-Colored Fentanyl Used to Target Young Americans (08/30/22)
National – Drug Checking Information (Test Strips)
- beats overdose
- BNTX – Harm Reduction
- DanceSafe – Products
- National Harm Reduction Coalition
- Novel Psychoactive Substances: Xylazine – Update (LAPPA 2024)
- Drug Checking Equipment, Needles/Syringes, and Drug Paraphernalia: Summary of State Laws (LAPPA 2024)
- Fentanyl Screening in Hospitals (LAPPA 2024)
- Fentanyl Testing Strip Training and Best Practices (ATTC/PTTC)
- Health risk communication strategies for drug checking services – A manual (EMCDDA 2023)
- An Introduction to Drug Checking and Its Role in Harm Reduction (NIJ 2022)
- Evaluation of Xylazine Test Strips (BTNX) for Drug Checking Purposes (CFSRE 2021)
- Fentanyl Test Strips (LAPPA 2021)
National – Drug Cleanup Information
- ATSDR – Agency for Toxic Substances and Disease Registry
- EPA – Voluntary Guidelines for Methamphetamine and Fentanyl Laboratory Cleanup
- Fentanyl Cleanup: Summary of State Laws (LAPPA 2023)
- National Clandestine Laboratory Register Data (DEA)
- Use-Related Methamphetamine Contamination in Managed Housing (NAIHC 2021)
- Voluntary Guidelines for Methamphetamine and Fentanyl Laboratory Cleanup (EPA 2021)
- Guidelines for Law Enforcement for the Cleanup of Clandestine Drug Laboratories (DEA 2005)
National – Drug Court Program Information
- All Rise – (Formerly National Association of Drug Court Professionals NADCP)
- HHS – What are Drug Courts
- Indian Health Services – Wellness Courts
- Treatment Court Institute (AllRise)
- National Treatment Courts Resource Center
- National Institute of Justice (NIJ) – Overview of Drug Courts
- Adult Drug Courts – Factors Related to Eligibility and Acceptance of Offers to Participate in DOJ Funded Adult Drug Courts (GAO 2023)
- Federal Alternative-to-Incarceration Court Programs (USSC 2017)
National – Drug Free Workplace Information
- GSA Drug-Free Workplace Program
- MADD – Impaired Driving
- National Drug-Free Workplace Alliance (NDWA)
- National Drug-Free Workplace Alliance (NDWA) Webinar: Dangers of Drug Impaired Driving
- Network of Employers for Traffic Safety (NETS)
- OHRM – Drug-free Workplace
- SAFE Project
- SAMHSA – Drug-Free Workplace Programs
- SAMHSA – Federal Laws and Regulations
- US Department of Labor – Preventing Substance Use in the Workforce
- Building a Safer Workforce: Addressing Opioid Use Disorder in High-risk Industries (COSSUP 2024)
- HHS – Model Plan for a Comprehensive Federal Drug-Free Workplace Program (2023)
- Recovery-Ready Workplace Toolkit: Guidance and Resources for Private and Public Sector Employers (2023)
- Model Recovery Ready Workplaces Act (LAPPA 2023)
- Substance Use Disorders Recovery with a Focus on Employment (SAMHSA 2021)
- Workplace Prevention Basics: A guide for employers to identify and prevent opioid and other substance misuse in the workplace (SAMHSA 2021)
- Weed and Your Workforce: What You Need to Know (NSC 2016)
- HHS – Administrative and National Policy Requirements – Guidance Regarding Drug-Free Workplace Act (2014)
National – Drugged Driving Information
- All Rise – (Formerly National Association of Drug Court Professionals NADCP) – Impaired Driving Solutions
- Governors Highway Safety Association
- MADD – Impaired Driving
- National Alliance to Stop Impaired Driving (NASID)
- NHTSA – Drug Impaired Driving
- Network of Employers for Traffic Safety (NETS)
- ONDCP – Drugged Driving
- Responsibility.org
- Stop Drugged Driving
- Get Smart About Drugs – Drugged Driving—What You Should Know (2024)
- National Drug-Free Workplace Alliance (NDWA) Webinar: Dangers of Drug Impaired Driving (2024)
- Cannabis Consumers and Safe Driving: Responsible Use Messaging (2022)
- Drugged Driving: Summary of State Laws (LAPPA 2022)
- Drugged Driving Fact Sheet (LAPPA 2021)
- What You Should Know About Impaired Driving Among College Students (2021)
- Bad Influence: The Use of Legal and Illegal Drugs Is a Growing Menace on Our Roadways (AAA – 2016)
National – Electronic Prescribing Information
- CMS – E-Prescribing
- CMS Electronic Prescribing for Controlled Substances (EPCS) Program
- DEA – Electronic Prescribing for Controlled Substances (EPCS)
National – First Responder Deflection Program(s) Information
- CCVJ Veterans Justice Commission
- CJI – Crime and Justice Institute
- Civil Citation Diversion & Deflection Network (CCDDN)
- Envisaging the Future of Law Enforcement and Public Health Project (GLEPHA)
- First Responder Deflection Resource Library (BJA- COSSAP)
- Law Enforcement Against Drugs (L.E.A.D.)
- National Council for Mental Wellbeing – Deflection and Pre-Arrest Diversion to Prevent Opioid Overdose
- Operation 2 Save Lives (O2SL) & QRT National
- Police Assisted Addiction & Recovery Initiative (PAARI)
- Police, Treatment, and Community Collaborative (PTACC)
- Policing Project – Reimagine Public Safety – Centering Communities
- Treatment Alternatives for Safe Communities (TASC)
- US Sentencing Commission – Alternatives to Incarceration and Diversion Programs
- Spreading the Word About COSSUP Court Navigation Programs (2024)
- Model Medicaid Reentry Section 1115 Demonstration Waiver Act (LAPPA 2024)
- Emerging Practices to Elevate and Replicate Community Responder Programs Nationwide (2024)
- Deflection and the Deflection Pathways – Fact Sheet (LAPPA 2023)
- Program-based Strategies for Opioid Diversion in the Fire and Emergency Services (CHJ 2023)
- NCSL Report: The Legislative Primer Series for Front-End Justice: Deflection and Diversion (August 2023)
- The Nexus Between Jail Diversion and Crisis Services (NASMHPD 2023)
- Building the Table: Advancing Race Equity in the Criminal Legal System (2022)
- Overview of Juvenile Deflection in the United States: A State-by-State Comparison (R Street 2022)
- Deflection & Pre-Arrest Diversion: Solutions Action Plan (SAP) – (PTACC/CHJ 2022)
- Model Law Enforcement and Other First Responder Deflection Act (LAPPA 2021)
- Report of the National Survey to Assess First Responder Deflection Programs in Response to the Opioid Crisis – Final Report (2021)
- Statewide Policies Relating to Pre-Arrest Diversion and Crisis Response (R Street 2019)
National – Medical Marijuana, Recreational Marijuana & CBD Information
- CDC – Cannabis and Public Health
- CDC – About CBD
- Collaborative for Cannabinoid Science & Safety (CCSS)
- DISA
- DISA – Marijuana Legality by State
- FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD)
- Marijuana – Know the Truth – A DFAF Initiative
- NMI – National Marijuana Initiative (HIDTA)
- SAM – Smart Approached to Marijuana
- USDA – Hemp Production
- The Federal Status of Marijuana and the Policy Gap with States (CRS 2024)
- Go-to Guide: Understanding Marijuana Use During Pregnancy and Parenthood (DFAF 2024)
- Cannabidiol (CBD) – Potential Harms, Side Effects, and Unknowns (SAMHSA 2023)
- Marijuana Use During Pregnancy – Fast Facts (DFAF 2022)
- A Panel Study of the Effect of Cannabis Use on Mental Health, Depression and Suicide in the 50 States ( DFAF 2022)
- The Status of Unregulated Cannabinoid Products in the Marketplace (CCSS 2022)
- Marijuana: Comparison of State Laws Allowing Use for Medicinal Purposes (NAMSDL 2017)
National – Medication Assisted Treatment (MAT) Information/Programs
- CDC – Medications for Opioid Use Disorder (MOUD) Study
- CMS – Opioid Treatment Programs (OTP)
- DEA – Medication Assisted Treatment
- FDA – Information about Medications for Opioid Use Disorder (MOUD)
- JCOIN – Justice Community Opioid Innovation Network – Coordination and Translation Center (CTC)
- Indian Health Services – Medication Assisted Recovery
- Indian Health Services – Tele-MAT
- National Center on Substance Abuse and Child Welfare (NCSAW) – Medication Assisted Treatment
- National Council for Mental Wellbeing – Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit
- SAMHSA – Medications for Substance Use Disorders
- SAMHSA – Removal of DATA Waiver (X-Waiver) Requirement
- SAMHSA – Methadone Take-Home Flexibilities Extension Guidance
- Model Pharmacist Collaboration for Medication for Opioid Use Disorder Act (LAPPA 2024)
- DEA and HHS joint letter on Medications for Opioid Use Disorder (MOUD) (March 8, 2024)
- FDA – Considerations for Buprenorphine Initiation and Maintenance Care – Public Meeting Summary (August 2023)
- Performance Measures for Medication-Assisted Treatment in Correctional Settings A Framework for Implementation (LAPPA) (2023)
- Policy Priority Roundtable Summary Report – Improving Buprenorphine Access in Pharmacy Settings (SAMHSA 2023)
- DEA – (Video) MATE Act Training Requirements (June 2023)
- FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder (May 23, 2023)
- Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment (May 2023)
- CDC – Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021 (2023)
- PEW – Overview of Opioid Treatment Program Regulations by State (2022)
- A Guide to DEA Narcotic Treatment Program Regulations (2022)
- Medication-Assisted Treatment in the Courtroom – A Benchcard for Judicial Professionals Serving Parents and Children by Opioid Use Disorders (NCSACW 2021)
- SAMHSA – Buprenorphine Quick Start Guide (2021)
- Indian Health Services – Medication Assisted Treatment Using Tele-MAT (2020)
- DEA – Use of Telemedicine While Providing Medication Assisted Treatment (MAT) (2018)
- Federal Guidelines for Opioid Treatment Programs (2015)
National – Naloxone Program(s)/Information
- BJA-National Training and Technical Assistance Center (NTTAC) – Naloxone Toolkit for Law Enforcement
- End Overdose
- Get Naloxone Now
- Information about Naloxone and Nalmefene (FDA)
- Lifesaving Naloxone (CDC)
- Musicians for Overdose Prevention
- NIDA – Naloxone Drug Facts
- National Naloxone Map
- National Harm Reduction Coalition
- Prescription Drug Abuse Policy System (PDAPS) – Naloxone Access Prevention Laws
- Rural Health Information Hub – Naloxone Expansion Programs
- Start Healing Now – Overdose Aid Kit Locations
- SAMHSA – Opioid Overdose Reversal Medications (OORM)
- Victoria’s Voice Foundation – Get Naloxone – Get. Give. Save.
- White House Challenge to Save Lives from Overdose
- Model Overdose Reversal Agents Act (LAPPA 2024)
- Policy Roundtable on Expanding Naloxone Access in Schools (CEPOP 2023)
- FDA Approves First Over-the-Counter Naloxone Nasal Spray (March 29, 2023)
- Enhancing Harm Reduction Services in Health Departments – Harm Reduction Vending Machines (July 2023)
- Naloxone Access: Summary of State Laws (LAPPA 2023)
- Naloxone Economic View – Summary Report (March 2023)
- Model Expanded Access to Emergency Opioid Antagonists Act (LAPPA 2021)
- Evaluation Profile for Naloxone Distribution Programs (CDC 2021)
- Guide to Developing and Managing Overdose Prevention and Take-Home Naloxone Projects – Harm Reduction Coalition (2012)
National – Needle Exchange Program (NEP) & Syringe Services Programs (SSP) Information
- National Harm Reduction Coalition – Syringe Access
- NIH – Syringe Services Programs
- North America Syringe Exchange Network (NASEN)
- Syringe Services Programs (SSPs) – CDC
- Drug Checking Equipment, Needles/Syringes, and Drug Paraphernalia: Summary of State Laws (LAPPA 2024)
- NACo – Syringe Services Programs: A NACo Opioid Solutions Strategy Brief (2023)
- Model Syringe Services Program Act (LAPPA) (2021)
- Syringe Services Programs – Technical Package (2020)
- Peer Delivered Syringe Exchange Toolkit – Harm Reduction Coalition (2012)
National – Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal (NOWS) Programs/Information
- To The Moon And Back
- A Reuters Investigation – The most vulnerable victims of America’s opioid epidemic “Helpless & Hooked”
- CDC – About Opioid Use During Pregnancy
- MAT-LINK: MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment for Opioid Use Disorder during Pregnancy
- National Center on Substance Abuse and Child Welfare – Neonatal Abstinence Syndrome
- RCORP Neonatal Abstinence Syndrome (HRSA)
- DFAF – Go-to Guide: Understanding Marijuana Use During Pregnancy and Parenthood (2024)
- Evidence-Based, Whole-Person Care for Pregnant People who have Opioid Use Disorder (SAMHSA March 2024)
- Substance Use During Pregnancy and Child Abuse or Neglect (LAPPA 2024)
- Model Substance Use During Pregnancy and Family Care Plans Act (LAPPA) (2023)
- Resources for Professionals Working with Pregnant and Parenting People Affected by Substance Use Disorders (2023 – SAMHSA)
- Working with Child Protective Services to Support Pregnant and Parenting People, Their Infants, and Families Affected by Substance Use Disorders: a Factsheet for Healthcare Providers (2023 – SAMHSA)
- Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) – NIH 2023
- Substance Use During Pregnancy and Family Care Plans – (LAPPA 2022)
- DFAF – Marijuana Use During Pregnancy – Fast Facts (2022)
- Parental Substance Use as Child Abuse (Child Welfare Information Gateway) (2019)
- A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders – SAMHSA 2016
National – Opioid Litigation Proceeds Information
- National Academy for State Health Policy – State Opioid Settlement Spending Decisions
- National Association of Attorneys General – Opioids
- National Opioids Settlement
- National Opioid Official Settlement
- Opioid Settlement Tracker
- Principles for the Use of Funds From the Opioid Litigation (John Hopkins)
- The Principles Quick Guide to Creating a Settlement Council (NACO 2023)
- Tribal Opioid Settlements
National – Overdose Prevention Centers (OPC), Supervised Consumption Sites (SCS), Supervised Injection Facilities (SIFs) Information
- Drug Policy Alliance – Overdose Prevention Centers
- CATO Briefing Paper: Overdose Prevention Centers (2023)
- astho: Legal Mapping of Harm Reduction Laws and Overdose Prevention Center Legislation (2023)
- National Institutes of Health (NIH) – Overdose Prevention Centers (OPC) (2022)
- Reduced Emergency Department Visits and Hospitalization with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States (2022)
- Institute for Clinical and Economic Review (ICER) – Supervised Injection Facilities and Other Supervised Consumption Sites: Effectiveness and Value (2020)
- Safer Consumption Spaces in the United States: Uniting for a National Movement – Project Reform (2016)
National – Overdose Surveillance/Reporting Programs
- CDC – Drug Overdose Surveillance and Epidemiology (DOSE) System
- CDC – Overdose Data to Action (OD2A)
- CDC – Overdose Resource Exchange (ORE)
- CSTE – Overdose Surveillance Capacity Building
- End the Epidemic – Overdose Surveillance
- National Center for Fatality Review and Prevention
- Overdose Fatality Review Program (BJA-COSSAP)
- Overdose Fatality Review – Resource Library (BJA- COSSUP)
- Public Health and Safety Team (PHAST)
- State and National Overdose Web (SNOW)
- ODMAP – Statewide Implementation Strategies (2024)
- Legal Mapping of Overdose Fatality Review Committees and Prescription Drug Monitoring Programs (2024)
- Overdose Fatality Review – Fact Sheet (LAPPA 2022)
- Overdose Fatality Review – Data Instrument Guidance (BJA- COSSUP 2021)
- Model Overdose Fatality Review Teams Act (LAPPA 2021)
- Model Overdose Mapping and Response Act (LAPPA 2020)
National – Pain Management Information
- American Academy of Pain Medicine – Clinical Guidelines
- AMA – End the Epidemic
- CDC – Rx Awareness
- CMS Opioid Prescribing
- DEA – Diversion Control
- HHS – Safe Opioid Prescribing
- NIDA – Opioids and Pain Management
- NIH – Reducing Opioid-Related Harms to Treat Chronic Pain (IMPOWR and MIRHIQL)
- NaRCAD
- VA/DoD Clinical Practice Guidelines – Use of Opioids in the Management of Chronic Pain
- AAP – Opioid Prescribing for Acute Pain Management in Children and Adolescents in Outpatient Settings: Clinical Practice Guideline (2024)
- FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use (2023)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
- FDA – Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry (Draft Feb 2022)
- HHS – Pain Management Best Practices (2019)
- CDC – Guideline for Prescribing Opioids for Chronic Pain – Brief (2018)
- CDC – Checklist for Prescribing Opioids for Chronic Pain (2018)
- CDC – NonOpioid Treatments for Chronic Pain – Alternative Treatments Fact Sheet (2018)
- CDC – Assessing Benefits and Harms of Opioid Therapy – Brief (2018)
- CDC – Calculating Total Daily Dose of Opioids For Safer Dosage – Brief (2018)
- CDC – Guideline for Prescribing Opioids for Chronic Pain – United States 2016
National – Peer Recovery Support Services and Information
- Altarum
- National Center for Peer Support
- National Association of Peer Supporters (NAPS)
- NCSL – Peer Support Specialists
- Peer Support Specialists: A Growing Mental Health and Addictions Workforce (SAMHSA 2024)
- Peer Empower Hour: A Virtual Space for Connection, Support, and Networking (COSSUP 2024)
- Incorporating Peer Support Into Substance Use Disorder Treatment Services (SAMHSA 2023)
- National Model Standards for Peer Support Certification (SAMHSA 2023)
- Peer Support Services in Crisis Care (SAMHSA June 2022)
- Value of Peers Infographic (SAMHSA 2017)
National – Pill Press Information
- DEA: Pill Press Resources
- Pill Press Laws: A forgotten Aspect of Counterfeit Drug Making (Update 2024)
- Pill Presses: Summary of State Laws (LAPPA 2023)
- Pill Press Laws: A forgotten Aspect of Counterfeit Drug Making (2021)
- Illegal Pill Presses: An Overlooked Threat to American Patients (2019)
National – Prescription Drug Drop-Off Information
- American Medicine Chest Challenge
- DEA – Controlled Substance Public Disposal Locations – Search Utility
- NABP – Drug Disposal Locator
- Rx Drug Drop Box – NADDI
- Drug Take-Back and Disposal Program: Summary of State Laws (LAPPA 2023)
- The Model Drug Take-Back and Disposal Program Act – LAPPA (June 2023)
- Safe Drug Disposal – A Guide for Communities Seeking Solutions (PDFK 2015)
National – Prescription Drug Importation Program Information
- FDA Authorizes Florida’s Drug Importation Program (2024)
- FDA – Letter of Authorization for Florida’s Section 804 Importation Program (2024)
- KFF – FAQs on Prescription Drug Importation (2024)
- NCSL – State Drug Wholesale Importation Programs (2024)
- Status of US Prescription Drug Importation Pathways (2024)
- Congressional Research Service – Prescription Drug Importation (2022)
- KFF – 10 FAQs on Prescription Drug Importation (2021)
- Presidential Executive Order 14036 – Promoting Competition in the American Economy (7/9/2021)
- Food and Drug Regulation – Importation of Prescription Drugs (Doc ID FDA-2019-N-5711-1252) – Final Rule
National – Prescription Drug Monitoring Program Information
- CDC – Prescription Drug Monitoring Programs (PDMPs)
- HealthIT.gov – Prescription Drug Monitoring Programs
- NABP – PMP InterConnect – Connecting State Prescription Monitoring Programs Nationwide
- NASCSA – Controlled Substances & PMP
- PDMP-TTAC – Prescription Drug Monitoring Program Training and Tactical Assistance Center (Brandeis University)
- PMP Aware (Bamboo Health)
- COSSUP – Prescription Drug Monitoring Program Highlights for August 2024
- CDC – Leveraging Prescription Drug Monitoring Program (PDMP) Data in Overdose Prevention and Response (2021)
- NAMSDL – Interjurisdictional Sharing of Prescription Drug Monitoring Program (PDMP/PMP) Data – Map (2019)
- NAMSDL – Prescriber Mandated Use of Prescription Drug Monitoring Programs (PDMP/PMPs) – Map (2019)
- Prescription Drug Monitoring Programs Report – Evidence Based Practices to Optimize Prescriber Use (PEW Charitable Trusts 2016)
National – Prevention Resources – General
- A Division for Advancing Prevention & Treatment (ADAPT) – HIDTA
- Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP) Resource Center
- Division of Adolescent and School Health (DASH) – CDC
- Drug Free America Foundation
- Facing Fentanyl – Voices for Awareness
- Foundation for Opioid Response (FORE)
- Get Smart About Drugs (DEA)
- Health Education Curriculum Analysis Tool (HECAT) – CDC
- Hepatitis B National Task Force
- NACoA – National Association for Children of Addiction
- NaRCAD
- National Harm Reduction Coalition
- NIH – Heal Initiative
- NIOSH – National Institute for Occupational Safety and Health
- ODMAP – HIDTA
- Operation Prevention (DEA)
- Opioid Affected Youth Initiative
- PDMP – TTAC
- Public Health and Safety Team (PHAST) – CDC
- Rural Community Toolbox – Resources
- Rural Health Information (RHI) Hub
- SAFE Project
- Shatterproof
- Trust for America’s Health – Prevention and Public Health Stories in the States
- Victoria’s Voice Foundation
- We Believe
- Overdose Prevention and Response Toolkit (2024 SAMSHA)
- Preventing or Reducing Opioid Abuse and Overdose: Selected Resources (2016 SAMSHA)
National – Prevention Resources – Community
- Alexander Neville Foundation
- Bringing Recovery Supports to Scale (BRSS) Technical Assistance Center Strategy (TACS) – SAMHSA
- Campus Drug Prevention
- Drug Free America Foundation
- Dougie the Drug Dog
- Facing Fentanyl – Voices for Awareness
- Families Against Fentanyl (FAF)
- Foundation for Opioid Response (FORE)
- Get Smart About Drugs – DEA
- Indian Health Services – Opioid Use Disorder and Pain
- Institute for Behavior and Health
- Just Think Twice – Get the Facts About Drugs
- Lives Project, The (National Crime Prevention Project)
- Lock Your Meds – Informed Families Partnership
- Monitoring the Future
- National Harm Reduction Coalition
- Natural High
- NCYI – National Center for Youth Issues
- Native Connections (SAMHSA)
- One Choice
- One Pill Can Kill (DEA)
- Operation Parent
- Operation Prevention – DEA
- Overdose Prevention (CDC)
- Partnership to End Addiction – Community Resources
- Prevent Opioid Abuse
- Pro Athletes in Recovery
- R Street Institute
- Rural Community Toolbox
- Rx Awareness Campaign (CDC)
- SAFE Project
- Stepping Up
- Stop Overdose (CDC)
- SUPE – Substance Use Prevention Education
- Timbi Talks About Addiction
- Treatment Alternatives for Safe Communities (TASC)
- Tribal Training and Technical Assistance Center (SAMHSA)
- Up and Away
- Vital Signs – Victoria’s Voice Foundation
- Online Health and Safety for Children and Youth: Best Practices for Families and Guidance for Industry (SAMSHA 2024)
- Overdose Prevention and Response Toolkit (2024 SAMSHA)
- Prevention With Purpose: A Strategic Planning Guide for Preventing Drug Misuse Among College Students (2024)
- Maintaining Fidelity to ACT: Current Issues and Innovations in Implementation (SAMHSA 2023)
- Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide (SAMHSA 2023)
- Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide (SAMHSA 2023)
- Engaging Parents and Youths with Lived Experience: Strengthening Collaborative Policy and Practice Initiatives for Families with Mental Health and Substance Use Disorders (2021)
- Community Engagement: An Essential Component of an Effective and Equitable Substance Use Prevention System (SAMHSA 2021)
- Opioid Overdose Prevention Toolkit – Facts for Community Members (2016 SAMSHA)
- Opioid Overdose Prevention Toolkit – Safety Advice for Patients & Family Members (2016 SAMSHA)
- Medicines and You: A Guide for Older Adults (HHS-AoA 2016)
- Prescription Medication Misuse and Abuse Among Older Adults (2012 HHS-AoA Brief)
National – Prevention Resources – First Responders
- CDC – Fentanyl: Emergency Responders at Risk
- CDC – Fentanyl: Emergency Responders Toolkit
- Naloxone Toolkit for Law Enforcement – BJA NTTAC
- SAMSHA – First Response: Working on the Front Lines of the Opioid Crisis Training Course
- US CBP – Frontline Against Fentanyl
- SAMSHA – Connecting Communities to Substance Use Services: Practical Approaches for First Responders (2023)
- Opioid Overdose Prevention Toolkit – Five Essential Steps for First Responders (2018 SAMSHA)
National – Prevention Resources – Healthcare
- End the Epidemic
- Foundation for Opioid Response (FORE)
- Interagency Pain Research Coordinating Committee (NIH)
- NaRCAD
- National Clinician Consultation Center – Substance Use Management (USCF)
- Overdose Prevention and Response Toolkit – Information for Prescribers (2024 SAMSHA)
- American Hospital Association – Opioid Toolkit – Stem the Tide (2018)
- Opioid Induced Respiratory Depression: New Tools for Risk Assessment (2017)
- CDC Guideline for Prescribing Opioids for Chronic Pain – United States 2016
- How State Health Departments Can Use the Spectrum of Prevention to Address Neonatal Abstinence Syndrome (2015 – ASTHO – Companion Report)
National – Prevention Resources – Tribal & Tribal Opioid Response (TOR)
- American Indian and Alaska Native (AI/AN): Tribal Affairs (SAMHSA)
- Indian Health Services – Alcohol and Substance Abuse Branch (ASAB)
- Indian Health Services – Opioid Use Disorder and Pain
- National Congress of American Indians (NCAI)
- Native Connections (SAMHSA)
- Office of Tribal Affairs and Policy (OTAP) – News and Events
- Opioid Overdose Prevention in Tribal Communities (CDC)
- Opioid Response Network
- Rural Health Information Hub: Considerations for American Indian/Alaska Native and Tribal Populations
- Tribal Access to Justice Innovation
- Tribal Action Plan (TAP) – (SAMHSA)
- Tribal Training and Technical Assistance Center (SAMHSA)
- Preventing Underage Substance Use in Tribal Communities (COSSAP 2021)
- Tribal Opioid Response – National Strategic Agenda (2019)
- Tribal Responses to Drug Overdoses (COSSAP 2020-2023)
National – Prevention Resources – Schools
- ARS – Association of Recovery Schools
- Campus Drug Prevention – Resources
- Get Smart About Drugs (DEA)
- Natural High
- Operation Prevention (DEA)
- SAFE Project
- Substance Use Prevention: A Resource Guide for School Staff (ONDCP)
- We Believe
- Prevention with a Purpose: A Strategic Planning Guide for Preventing drug Misuse Among College Students (DEA 2024)
- Fentanyl and Opioids: Preventing Overdoses and Related Emergencies at K-12 and Higher Education Campuses – Fact Sheet
- Policy Roundtable on Expanding Naloxone Access in Schools (CEPOP 2023)
- Model School Response to Drugs and Drug-Related Incidents Act (LAPPA – May 2023)
National – Prison/Jail Programs/Information
- All Rise – (Formerly National Association of Drug Court Professionals NADCP)
- Jail-Based MAT Mentoring Sites (BJA-COSSAP)
- Jail Resource Center (BJA-COSSAP)
- JCOIN – Justice Community Opioid Innovation Network – Coordination and Translation Center (CTC)
- The National Reentry Resource Center
- Stepping Up
- VERA – Overdose Deaths and Jail Incarceration
- Model Access to Medication for Addiction Treatment in Correctional Settings Act (LAPPA Sept 2024)
- Best Practices for Successful Reentry From Criminal Justice Settings for People Living With Mental Health Conditions and/or Substance Use Disorders (SAMHSA 2023)
- Performance Measures for Medication-Assisted Treatment in Correctional Settings A Framework for Implementation (LAPPA 2023)
- Guidelines for Managing Substance Withdrawal in Jails – BJA Toolkit June 2023
- Guidelines for Managing Substance Withdrawal in Jails – BJA Ppt Presentation July 2022
- Residential Substance Abuse Treatment for State Prisoners (RSAT) – BJA (July 2022)
- Managing Substance Withdrawal in Jails: A Legal Brief (BJA 2022)
- Medication for Addiction Treatment in Correctional Settings (LAPPA 2022)
- Creating Reach Beyond the Jail Walls: An Implementation Guide for Harm Reduction Re-Entry Wrap Around Services Programs (2021)
- WSU – Center for Behavioral Health and Justice – Expanding naloxone distribution in county jails (2021)
- The Stigmatization of Justice-involved Individuals with Substance Use Disorders (LAPPA 2021)
- Opioid Use Disorder Treatment in Jails and Prisons (PEW 2020)
- National Commission on Correctional Health Care – Naloxone in Correctional Facilities for the Prevention of Opioid Overdose Deaths (2020)
- Jail-Based Medication Assisted Treatment – Promising Practices, Guidelines, and Resources for the Field (2018)
National – Public Safety Announcements
- Ann Marie’s Rx Awareness Story
- BCBSLA – Fentanyl Kills – About Fentanyl and Opioids – YouTube
- BCBSLA – Fentanyl Kills – Alex’s Story – YouTube
- BCBSLA – Fentanyl Kills – Victoria’s Story – YouTube
- Brenda’s Rx Awareness Story
- Dead on Arrival (Documentary) – YouTube
- ESC Substance Abuse Prevention – Behind the Scenes Footage
- I Can Tell :30
- Judy’s Rx Awareness Story
- McGruff Stops Big Crime: Take a Bite Out of Fake Pills
- Mike’s Rx Awareness Story
- Natural High – Fentanyl PSA – You Tube
- PGCPS PSA – Fentanyl – YouTube
- Teresa’s Rx Awareness Story
- 2024 FentAlert Challenge Winners – YouTube
National – SBIRT (Screening, Brief Intervention and Referral to Treatment) Information
- NIDA – Screening and Assessment Tools Chart
- NIDA – Screening Tools for Adolescent Substance Use
- NIAAA – Screening Tools for Adolescent Substance Use: A Practitioner’s Guide (2021)
- SAMHSA – Screening, Brief Intervention, and Referral to Treatment (SBIRT)
National – Sober Living Homes/Recovery Residence Information
- National Alliance for Recovery Residences (NARR)
- National Sober Living Association (NSLA)
- Best Practices for Recovery Housing (SAMHSA 2023)
- Summary and Impact Analysis of State Laws Addressing Predatory and Unethical Substance Use Disorder Treatment Practices (NAMSDL 2019)
National – Support Services & Coalition Information
- AACAP – American Academy of Child & Adolescent Psychiatry – Substance Use Resource Center
- The Addiction Center
- Addiction Technology Transfer Center Network (ATTC)
- The Addicts Mom (Support & Advocacy)
- Addiction Resource
- American Association for the Treatment of Opioid Dependence (AATOD)
- APALD – Association of People Against Lethal Drugs
- beats overdose
- Coaching into Care – US Dept of Veterans Administration
- Drug Addiction & Recovery Team (DART)
- Families Against Fentanyl (FAF)
- Fed Up!
- Find Support – SAMHSA
- Find Treatment – SAMHSA
- Healthcare Ready
- Healthy People 2030
- Helping to End Addiction Long-term (HEAL) Initiative (NIH)
- Informed Families
- The Lives Project
- Mental Health FIRST AID – 10 Tips for Talking About Addiction
- Narcotics Anonymous
- NACoA – National Association for Children of Addiction
- National Harm Reduction Coalition
- National Safety Council
- Natural High
- Never Use Alone – Hotline# (800) 484-3731
- Opioid Affected Youth Initiative
- Opioid Overdose Prevention Toolkit – Recovering from Opioid Overdose: Resources for Overdose Survivors & Family Members (2016 SAMSHA)
- Opioid Response Network
- Overdose Lifeline
- The Prevention Coalition
- Prevent Opioid Abuse
- Pro Athletes in Recovery
- Recovery Research Institute
- Recovered User Network (RUN)
- Rural Community Toolbox
- SAM – Smart Approached to Marijuana
- Sources of Strength
- Start with Hope
- SUPE – Substance Use Prevention Education
- “Talk. They Hear You” (SAMHSA)
- Victoria’s Voice Foundation
- We Believe
- YPR – Young People in Recovery
National – Telemedicine/Telehealth Information
- AMA – Telehealth Laws, Regulations & Policies
- DEA Diversion Control – Telemedicine
- HHS – Telehealth
- Medicaid.gov – Telemedicine
- Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (5/10/23)
- SAMHSA – Virtual Recovery Resources (2022)
- Telehealth and Substance Use Disorder Services in the Era of Covid 19: Review and Recommendations (2022)
- CMS – State Medicaid & CHIP Telehealth Toolkit (2021)
- Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders (SAMHSA 2021)
- DEA Information on Telemedicine (2020)
- DEA – Use of Telemedicine While Providing Medication Assisted Treatment (MAT) (2018)
National – Tribal & Tribal Opioid Response (TOR) Information
- Indian Health Services – Medication Assisted Recovery
- Indian Health Services – Tele-MAT
- Recovery Resources for American Indian and Alaska Natives (SAMHSA)
- Rural Community Toolbox – Resources
- Tribal Training and Technical Assistance Center (SAMHSA)
- Overcoming Stigma Related to Substance Use and Mental Health in Tribal Communities (COSSUP Aug 2024)
- Indian Health Services – Medication Assisted Treatment Using Tele-MAT (2020)
- An Environmental Scan of Tribal Opioid Overdose Prevention Responses: Community-Based Strategies and Public Health Data Infrastructure (Seven Directions 2019)
National – Training & Education Materials
- ATTC – Taking Action to Address Opioid Misuse
- Blue Cross and Blue Shield of Louisiana – Fentanyl Awareness
- Campus Drug Prevention
- CrimeSolutions.gov – Drug and Substance Abuse Education (National Institute of Justice) – Prevention & Education
- Dougie the Drug Dog
- EMOJI Codes and Social Media’s Illegal Drug Trade (2023)
- Faces and Voices of Recovery
- Facing Fentanyl Now
- Fentanyl Awareness – #justKNOW (DEA)
- Fentanyl – Why Fentanyl/Why Now (CADCA 2023)
- Forever 15 Project
- Informed Families
- Lives Project, The
- Medication-Assisted Treatment – An eBook for Parents & caregivers of teens & young adults addicted to opioids (2014)
- Medication Assisted Treatment Toolkit for Counselors (2021)
- NaRCAD
- Natural High
- N-DEWS Webinars
- One Pill Can Kill (DEA)
- Operation: Parent
- Operation Prevention (DEA)
- Overdose Prevention and Response Toolkit (2024 SAMSHA)
- PHAST Toolkit – CDC (2022)
- PSM – The Partnership for Safe Medicines
- Prescription Drug Impact in the Workplace (NSC 2014)
- Prescription for Disaster: How Teens Misuse Medicine (DEA 2023)
- The Problem of Neonatal Abstinence Syndrome – CDC- Ppt (2016)
- Rural Community Toolbox – Resources
- SUPE – Substance Use Prevention Education
- “Talk. They Hear You.” Campaign (SAMHSA)
- The Truth About Drugs – DrugFreeWorld.org
- Timbi Talks About Addiction
- Vital Signs – Victoria’s Voice Foundation
- What’s Trending: Youth Prescription Drug Misuse (CADCA 2024)
Last Updated 10/20/2024
Please report any broken links to tech@naddi.org
